For informational purposes only — not investment advice

← Back to signals

CVS

SHORTINSIDER BUY

CVS HEALTH CORP

Research: Finviz ↗·Perplexity ↗

Funds
3
Score
2.97
vs SPY
+0.2%
Stock return (since Q-end)
-5.9%
SPY return (since Q-end)
-6.1%
Current price
$80.04
Days to cover (short int.)
2.8d↑+8.5%
as of 2026-10-30 · shares short vs 2026-09-30

News Summary

Neutral

CVS Health beat Q3 2026 earnings expectations and raised full-year guidance, demonstrating strong operational execution with $108.4B in revenues and $2.09 adjusted EPS. However, the company announced a strategic reversal to split into two independent companies by H1 2028 amid regulatory scrutiny over vertical integration, introducing significant execution risk and uncertainty over the near-term direction of the business.

Red flags

  • •Major corporate restructuring (split into two companies) planned for H1 2028 creates execution risk and strategic uncertainty
  • •Split driven by regulatory and political pressure on vertical integration, suggesting ongoing compliance challenges
  • •CEO stated political criticism will likely continue even after the split, indicating unresolved regulatory headwinds

Funds Reducing / Exiting (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Glenview CapitalLarry Robbins1.3M-3,545,242$110M10.0%-73%Existing
Viking GlobalAndreas Halvorsen0−3.7M—1.1%-100%EXITED
Point72Steve Cohen0−2.0M—0.3%-100%EXITED

Shares Held reflects quarter-end positions for partial reductions. Funds that fully exited show 0 shares held. ∆ Shares is the change from the prior quarter. % of Fund is the prior-quarter position size — how much of the book was sold down.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Shah Prem SEVP and Group PresidentBUY24K$83.89$2.00M2026-11-06↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Dodge & CoxSC 13G/A50.0M3.9%2026-08-13↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

No trades dated since Jul 1, 2026.

Earlier trades (2) — dated outside this quarter's window, not counted in the badges
MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan Armstrongsenate—BUY$1,001 - $15,0002026-03-272026-07-21↗
Thomas H Tubervillesenate—SELL$1,001 - $15,0002024-08-262026-08-05↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Jul 1, 2026.